VYNE Therapeutics to Report Second Quarter 2021 Financial Results on August 12, 2021
BRIDGEWATER, N.J., July 27, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
Month: July 2021
Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
– First clinical trial to specifically study confirmed carbapenem-resistant Acinetobacter…
Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (“TLIS”), a company…
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
AFFiRiS to receive AC Immune stock valued at USD 58.7 million in exchange for its…
LAVA Therapeutics Announces Appointment of Amy Garabedian as General Counsel and Corporate Secretary
UTRECHT, The Netherlands and PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
SpringWorks Therapeutics Appoints Dr. James Cassidy as Chief Medical Officer
STAMFORD, Conn., July 27, 2021 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage…
Kinnate Biopharma Inc. to Participate in the 2021 Wedbush PacGrow Healthcare Conference
SAN FRANCISCO and SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors
LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor” or “the Company”) (NASDAQ:…
BioVie Presents Data Supporting use of NE3107 in the Treatment of Alzheimer’s Disease at 2021 Alzheimer’s Association International Conference
NE3107 Is the First Potentially Disease Modifying, Anti-Inflammatory Insulin Sensitizer Therapy In A Pivotal Phase…
GBT to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
SOUTH SAN FRANCISCO, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
Reported revenue was $163.0 million for the quarter, representing year-over-year growth of 86% and organic…
Kraig Biocraft Laboratories provides Spider Silk Production Update
ANN ARBOR, Mich., July 27, 2021 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the…
Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
R&D Facility in Frederick, MD is Expected to Provide Internal Capacity to Discover and Develop…
Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2021 Financial and Operational Results on August 10, 2021
BEDMINSTER, N.J., July 27, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB),…
Plus Strengthens Commercial RNL Supply Chain with Ten Year Exclusivity Agreement
Global agreement covers 186RNL manufacturing intermediate Manufacturer ABX Advanced Biochemical Compounds GmbH is key worldwide…
Day One Receives FDA Rare Pediatric Disease Designation for DAY101 for the Treatment of Pediatric Low-Grade Glioma
SOUTH SAN FRANCISCO, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN),…
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif., July…
CENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and Development
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 27, 2021 (GLOBE NEWSWIRE) — Centogene N.V….
Total Economic Impact Study Reveals 181% ROI and Payback Period of Less than Six Months for Livestorm Video Engagement Platform
Independent study evaluated the potential financial impact of Livestorm on customer organizations Livestorm offers the…